NCT02450032View on ClinicalTrials.gov

Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions
Gastric Cancer
Interventions
BIOLOGICAL

G17DT

Trial Locations (1)

G31 2 ER

Glasgow Royal Infirmary, Glasgow

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02450032 - Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer | Biotech Hunter | Biotech Hunter